Macomics Alternatives & Competitors
12 companies similar to Macomics — Macrophage Biology Revealed:Developing breakthrough approaches to macrophage act...
Companies similar to Macomics
Mestag Therapeutics
New therapies for inflammatory disease and cancer by targeting fibroblast immunology
Mosaic TX
Resolving cancer's complexity through the power of targeted drug combinations
CV6 Therapeutics, (NI) Ltd.
CV6 Therapeutics is dedicated to improving patients lives through the development of novel...
Attovia Therapeutics
Creating medicines for immune-mediated disease using ATTOBODY®, a proprietary biologics pl...
Rival Readout
Competing with Macomics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Xilio Therapeutics, Inc.
Focused on harnessing the immune system to achieve deep and durable clinical responses to...
Bicara Therapeutics
Pioneering bifunctional antibodies for targeted tumor modulation
FogPharma
Until everything is druggable.
MACROPHAGE PHARMA LIMITED
Empowering the immune system to combat cancer with precision-targeted therapies
Granza Bio
Reprogramming Immunity for Target-Specific Medicines
Anavo Therapeutics BV
UNLOCKING THE PHOSPHATASE TARGET CLASS
Alterome Therapeutics, Inc
To Life!
About Macomics
Macomics is a pioneering company established in 2020, positioned at the forefront of the Biotechnology and Health and Wellness industries. Headquartered in the United Kingdom, it focuses on a significant niche—developing precision medicines to modulate macrophages for cancer treatment, as highlighted by its compelling...
developing macrophage-targeting drugs, scientific research in macrophage biology, creating therapies for diseases with unmet medical needs
pharmaceutical companies, biotechnology firms, medical researchers, healthcare providers seeking novel treatments
Precision Medicines, Macrophage Modulation, Immunotherapy, Cancer Treatment, Tumour-Associated Macrophages, Immune System Modulation, Oncology Therapeutics, TME (Tumor Microenvironment), Immuno-oncology, Drug Development, Immune Defence, First-in-Class Therapies
B2B, Platform
Product Sales, Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Macomics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Macomics on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.